Challenge to Ivermectin Meta-Analysis is Defeated

This is the answer to Ivermectin skeptics and deniers who sought to discredit the original meta-analysis based on the questioned credibility of the included Elgazzar study. As we see below, the Elgazzar study is not only valid but its exclusion would not affect the outcome of the meta-analysis; that is Ivermectin has profound health benefits both prophylactically and as a therapeutic.

The post Challenge to Ivermectin Meta-Analysis is Defeated appeared first on Jim Proser.